Pulmonary aspergillosis and mucormycosis in a patient with COVID-19
Invasive pulmonary mucormycosis and aspergillosis are rare, life-threatening fungal infections. Most documented cases have been reported in patients with diabetes mellitus, neutropenia, or treatment with corticosteroids. Both infections have been recognized as secondary complications of COVID-19, es...
Main Authors: | Andre K. Johnson, Zeron Ghazarian, Kristina D. Cendrowski, Jon G. Persichino |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-06-01
|
Series: | Medical Mycology Case Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211753921000257 |
Similar Items
-
Comparison of Clinical Manifestation, Diagnosis, and Outcomes of Invasive Pulmonary Aspergillosis and Pulmonary Mucormycosis
by: Chun-Yu Lin, et al.
Published: (2019-11-01) -
INVASIVE ASPERGILLOSIS AND MUCORMYCOSIS IN ONCOHEMATOLOGICAL PATIENTS
by: O. V. Shadrivova, et al.
Published: (2018-07-01) -
COVID-19 Associated Invasive Pulmonary Aspergillosis: Diagnostic and Therapeutic Challenges
by: Aia Mohamed, et al.
Published: (2020-07-01) -
Invasive pulmonary aspergillosis and hyperthermia in an immunocompetent patient with COVID-19
by: Anne Haglund, et al.
Published: (2021-03-01) -
Tumor shape pulmonary mucormycosis associated with sinonasal aspergillosis in a diabetic patient
by: Sophie Point, et al.
Published: (2018-03-01)